Trial intelligence / Profile preview

Alpha-lipoic acid add-on for adolescent migraine prophylaxis

NCT04064814Phase 4Completed

Sponsor
AIIMS New Delhi
Start
Sep 2019
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of alpha-lipoic acid in migraine, sponsored by AIIMS New Delhi. Started Sep 2019; status: completed.

02

Drugs

alpha-lipoic acid
03

Conditions

migraine

Beyond the preview

Go deeper on NCT04064814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04064814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call